Catalyst Wire Dossier Catalyst Wire Dossier

Tyvyt (Sintilimab)

Sintilimab · Innovent Biologics
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Tyvyt (Sintilimab), covering 2024-05-10 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer [Phase 3]

See pricing